Stifel Upgrades Globus Medical (GMED) to Buy on discounted valuation
Tweet Send to a Friend
Stifel analyst Mathew Blackman upgraded Globus Medical (NYSE: GMED) from Hold to Buy with a price target of $61.00 (from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
